SOLICITATION NOTICE
65 -- MDMA/MDEA/MDA Reagent Bridge Contract
- Notice Date
- 10/10/2013
- Notice Type
- Presolicitation
- NAICS
- 325413
— In-Vitro Diagnostic Substance Manufacturing
- Contracting Office
- Department of the Navy, Bureau of Medicine and Surgery, NMLC, 693 Neiman Street, FT Detrick, Maryland, 21702-9203, United States
- ZIP Code
- 21702-9203
- Solicitation Number
- N62645-14-R-0036
- Archive Date
- 11/8/2013
- Point of Contact
- Nicholas J Dankanich,
- E-Mail Address
-
nicholas.dankanich@med.navy.mil
(nicholas.dankanich@med.navy.mil)
- Small Business Set-Aside
- N/A
- Description
- The Naval Medical Logistics Command intends to issue a one month bridge requirements contract with two, one month option periods on a sole source basis (IAW FAR 13.106-1(b)) with Microgenics Corporation, 46360 Fremont Blvd, Fremont CA, 94538-6406. Microgenics Corporation currently provides the Department of Defense (DOD) Drug Demand Reduction Program (DDRP) with Designer Methamphetamines (MDMA, MDEA and MDA) reagent kits under a contract N62645-13-D-5033. The current contract expires 31 October 2013. The estimated value of this contract is $130,800.00. The proposed bridge contract shall have a base period of performance from 01 November 2013 - 30 November 2013. The bridge contract shall be placed in anticipation of the award of a requirements contract resulting from competitive solicitation. Microgenics Corporation shall provide Designer Methamphetamines (MDMA, MDEA and MDA) reagent kits for the drug labs located in San Diego, California; Jacksonville, Florida; Great Lakes, Illinois; Lackland Air Force Base, Texas; Fort Meade, Maryland; Tripler Army Medical Center, Hawaii; and Dover Air Force Base, Delaware. This acquisition is being conducted under simplified acquisition procedures (IAW FAR 12, FAR 13, and FAR 16.503). There are no set-aside restrictions for this requirement. The intended procurement will be classified under North American Industry Classification System (NAICS) 325413 with a Small Business Size Standard of 500 employees. This notice of intent is not a request for competitive proposals and no solicitation document exists for this requirement. However, parties interested in responding to this notice will need to submit technical data sufficient to determine capability in providing the same product. All capability statements received within 15 days after publication of this synopsis will be considered by the Government. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Capability statements shall be submitted by email only as a MS Word or Adobe PDF attachment to Nicholas Dankanich at Nicholas.Dankanich@med.navy.mil (in subject line reference: N62645-14-R-0036 MDMA/MDEA/MDA Reagent Kits Bridge). Statements are due no later than 24 October 2013, 3:00 PM Local Time. No phone calls accepted.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/DON/BUMED/N62645/N62645-14-R-0036/listing.html)
- Record
- SN03214761-W 20131012/131010233951-c149cb53b41a59b34c2e64c12046ba96 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |